These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3026605)

  • 21. Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.
    Einhorn LH; Crawford J; Birch R; Omura G; Johnson DH; Greco FA
    J Clin Oncol; 1988 Mar; 6(3):451-6. PubMed ID: 2832549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine.
    Alberto P; Brunner KW; Martz G; Obrecht J; Sonntag RW
    Cancer; 1976 Dec; 38(6):2208-16. PubMed ID: 187313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.
    Ihde DC; Deisseroth AB; Lichter AS; Bunn PA; Carney DN; Cohen MH; Veach SR; Makuch RW; Johnston-Early A; Abrams RA
    J Clin Oncol; 1986 Oct; 4(10):1443-54. PubMed ID: 3020181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.
    Bleehen NM; Girling DJ; Machin D; Stephens RJ
    Br J Cancer; 1993 Dec; 68(6):1157-66. PubMed ID: 7505104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 26. Parenteral intravenous nutrition (PIVN) as an adjunct to chemotherapy in small cell anaplastic lung carcinoma.
    Serrou B; Cupissol D; Plagne R; Boutin P; Carcassone Y; Michel FB
    Cancer Treat Rep; 1981; 65 Suppl 5():151-5. PubMed ID: 6286118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of adjuvant central iv hyperalimentation on the survival and response to treatment of patients with small cell lung cancer: a randomized trial.
    Clamon GH; Feld R; Evans WK; Weiner RS; Moran EM; Blum RH; Kramer BS; Makuch RW; Hoffman FA; DeWys WD
    Cancer Treat Rep; 1985 Feb; 69(2):167-77. PubMed ID: 2982491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot studies of superfractionated radiotherapy and combination chemotherapy in limited oat cell carcinoma of the bronchus.
    Hodson DI; Malaker K; Meikle AL; Levitt M
    Int J Radiat Oncol Biol Phys; 1984 Oct; 10(10):1941-5. PubMed ID: 6092307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer.
    Park YJ; Koh EH; Kim J; Roh JK; Chang J; Ahn CM; Sohn HY; Kim SK; Lee WY; Kim K
    Yonsei Med J; 1989; 30(1):30-7. PubMed ID: 2545051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung.
    Young JA; Dillman RO; Seagren SL; Taetle R; Rentschler RE; Lea JW; Lehar TJ; Green MR; Stanton W; Mendelsohn J; Royston I
    Cancer Treat Rep; 1982 Jun; 66(6):1399-401. PubMed ID: 6282459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
    Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
    Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Bitran JD; Desser RK; DeMeester T; Golomb HM
    JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment results in unselected small cell bronchial carcinoma patients].
    Mende S; Bleichner F; Hofmann A; Meuret G; Vogel KH
    Onkologie; 1982 Jun; 5(3):146-9. PubMed ID: 6289209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four-drug chemotherapy regimens.
    Nõu E; Brodin O; Bergh J
    Cancer; 1988 Sep; 62(6):1079-90. PubMed ID: 2457422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of small cell lung cancer with VP-16, vincristine, doxorubicin (Adriamycin), cyclophosphamide (EVAC), and high-dose chest radiotherapy.
    Goodman GE; Miller TP; Manning MM; Davis SL; McMahon LJ
    J Clin Oncol; 1983 Aug; 1(8):483-8. PubMed ID: 6321685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study.
    Aisner J; Goutsou M; Maurer LH; Cooper R; Chahinian P; Carey R; Skarin A; Slawson R; Perry MC; Green MR
    J Clin Oncol; 1992 Aug; 10(8):1230-6. PubMed ID: 1321892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study.
    Kies MS; Mira JG; Crowley JJ; Chen TT; Pazdur R; Grozea PN; Rivkin SE; Coltman CA; Ward JH; Livingston RB
    J Clin Oncol; 1987 Apr; 5(4):592-600. PubMed ID: 3031226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial.
    Souhami RL; Rudd R; Ruiz de Elvira MC; James L; Gower N; Harper PG; Tobias JS; Partridge MR; Davison AG; Trask C
    J Clin Oncol; 1994 Sep; 12(9):1806-13. PubMed ID: 8083704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.